In this prognostic study of PMBR outcomes, an internally validated ML model trained on both structured and unstructured clinical data was used to predict 1-year major complications. Such models support personalized risk assessment, inform decision-making, and provide a foundation for future externally validated and prospectively tested decision-support tools.
Shaheen et al. (Wed,) studied this question.